Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

77.28
+1.181.55%
Post-market: 77.09-0.1900-0.25%16:17 EDT
Volume:5.64M
Turnover:420.60M
Market Cap:10.07B
PE:-131.35
High:77.58
Open:73.50
Low:70.94
Close:76.10
52wk High:102.81
52wk Low:11.16
Shares:130.29M
Float Shares:118.00M
Volume Ratio:1.01
T/O Rate:4.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5884
EPS(LYR):-0.3490
ROE:-9.40%
ROA:-5.05%
PB:12.20
PE(LYR):-221.40

Loading ...

Stock Track | 10x Genomics Plummets 8.52% Intraday After Q1 Report Shows Revenue Decline and License Revenue Plunge

Stock Track
·
May 08

Piper Sandler Keeps Their Hold Rating on 10x Genomics (TXG)

TIPRANKS
·
May 08

10x Genomics (TXG) Receives a Buy from Barclays

TIPRANKS
·
May 08

Stock Track | 10x Genomics Plunges 6.33% in Pre-Market Despite Earnings Beat as Revenue Declines and Analysts Revise Estimates

Stock Track
·
May 08

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and Telix Pharmaceuticals (OtherTLPPF)

TIPRANKS
·
May 08

10x Genomics Q1 EPS $(0.10) Beats $(0.30) Estimate, Sales $150.843M Beat $146.355M Estimate.

Benzinga Earnings
·
May 08

10x Genomics Q1 net loss narrows to $13.5 million; revenue drops 3% to $150.8 million

Reuters
·
May 08

BRIEF-10X Genomics Q1 Revenue USD 150.8 Million Vs. IBES Estimate USD 146.4 Million

Reuters
·
May 08

10x Genomics Inc: Maintaining Its Full Year 2026 Revenue Guidance

THOMSON REUTERS
·
May 08

10x Genomics Inc - Q1 2026 Revenue Excludes One-Time License and Royalty Revenue

THOMSON REUTERS
·
May 08

Press Release: 10x Genomics Reports First Quarter 2026 Financial Results

Dow Jones
·
May 08

Does Atera’s New Spatial Biology Platform Change The Bull Case For 10x Genomics (TXG)?

Simply Wall St.
·
May 02

Earning Preview: 10x Genomics, Inc. this quarter’s revenue is expected to increase by 10.50%, and institutional views are bullish

Earnings Agent
·
May 01

10x Genomics to join BofA Securities Healthcare Conference fireside chat

Reuters
·
Apr 30

Is Atera’s New Spatial Biology Platform Altering The Investment Case For 10x Genomics (TXG)?

Simply Wall St.
·
Apr 22

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Brookdale Senior Living (BKD) and 10x Genomics (TXG)

TIPRANKS
·
Apr 21

10x Genomics Is Maintained at Neutral by B of A Securities

Dow Jones
·
Apr 20

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Arrowhead Pharmaceuticals (ARWR) and Legend Biotech (LEGN)

TIPRANKS
·
Apr 20

10x Genomics, Inc. : Bofa Global Research Raises Price Objective to $30.00 From $21.00

THOMSON REUTERS
·
Apr 20

U.S. RESEARCH ROUNDUP-Carpenter Technology, IBM, Ulta Beauty

Reuters
·
Apr 20